19-11131982-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000527.5(LDLR):​c.*666T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.67 in 187,572 control chromosomes in the GnomAD database, including 43,670 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.66 ( 34364 hom., cov: 28)
Exomes 𝑓: 0.71 ( 9306 hom. )

Consequence

LDLR
NM_000527.5 3_prime_UTR

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.0310

Publications

66 publications found
Variant links:
Genes affected
LDLR (HGNC:6547): (low density lipoprotein receptor) The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. The encoded protein is normally bound at the cell membrane, where it binds low density lipoprotein/cholesterol and is taken into the cell. Lysosomes release the cholesterol, which is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2022]
SPC24 (HGNC:26913): (SPC24 component of NDC80 kinetochore complex) Predicted to be involved in cell division. Located in nucleolus and nucleoplasm. Part of Ndc80 complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 19-11131982-T-C is Benign according to our data. Variant chr19-11131982-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 328070.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.771 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LDLRNM_000527.5 linkc.*666T>C 3_prime_UTR_variant Exon 18 of 18 ENST00000558518.6 NP_000518.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LDLRENST00000558518.6 linkc.*666T>C 3_prime_UTR_variant Exon 18 of 18 1 NM_000527.5 ENSP00000454071.1

Frequencies

GnomAD3 genomes
AF:
0.661
AC:
100191
AN:
151614
Hom.:
34352
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.462
Gnomad AMI
AF:
0.630
Gnomad AMR
AF:
0.783
Gnomad ASJ
AF:
0.679
Gnomad EAS
AF:
0.721
Gnomad SAS
AF:
0.696
Gnomad FIN
AF:
0.744
Gnomad MID
AF:
0.671
Gnomad NFE
AF:
0.733
Gnomad OTH
AF:
0.672
GnomAD4 exome
AF:
0.710
AC:
25460
AN:
35840
Hom.:
9306
Cov.:
0
AF XY:
0.707
AC XY:
13360
AN XY:
18894
show subpopulations
African (AFR)
AF:
0.383
AC:
216
AN:
564
American (AMR)
AF:
0.808
AC:
2688
AN:
3326
Ashkenazi Jewish (ASJ)
AF:
0.693
AC:
423
AN:
610
East Asian (EAS)
AF:
0.717
AC:
1159
AN:
1616
South Asian (SAS)
AF:
0.654
AC:
3622
AN:
5542
European-Finnish (FIN)
AF:
0.706
AC:
1127
AN:
1596
Middle Eastern (MID)
AF:
0.641
AC:
59
AN:
92
European-Non Finnish (NFE)
AF:
0.722
AC:
14961
AN:
20708
Other (OTH)
AF:
0.675
AC:
1205
AN:
1786
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
331
662
993
1324
1655
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
178
356
534
712
890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.661
AC:
100251
AN:
151732
Hom.:
34364
Cov.:
28
AF XY:
0.664
AC XY:
49202
AN XY:
74146
show subpopulations
African (AFR)
AF:
0.462
AC:
19114
AN:
41330
American (AMR)
AF:
0.783
AC:
11911
AN:
15210
Ashkenazi Jewish (ASJ)
AF:
0.679
AC:
2356
AN:
3470
East Asian (EAS)
AF:
0.721
AC:
3704
AN:
5140
South Asian (SAS)
AF:
0.696
AC:
3348
AN:
4808
European-Finnish (FIN)
AF:
0.744
AC:
7842
AN:
10540
Middle Eastern (MID)
AF:
0.663
AC:
195
AN:
294
European-Non Finnish (NFE)
AF:
0.733
AC:
49805
AN:
67932
Other (OTH)
AF:
0.669
AC:
1404
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1572
3143
4715
6286
7858
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
800
1600
2400
3200
4000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.707
Hom.:
124042
Bravo
AF:
0.657
Asia WGS
AF:
0.680
AC:
2363
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hypercholesterolemia, familial, 1 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Jul 21, 2017
Department of Human Genetics, Laborarztpraxis Dres. Walther, Weindel und Kollegen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Due to the increased occurrence of the mutation (>= 5%) and the current estimates of databases (LOVD 3), this variant is classified as likely benign.

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Familial hypercholesterolemia Benign:1
Jun 30, 2022
GENinCode PLC
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
3.6
DANN
Benign
0.36
PhyloP100
0.031
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1433099; hg19: chr19-11242658; COSMIC: COSV52945335; COSMIC: COSV52945335; API